- Business
- China Aoyuan Group Limited (3883.HK) is an investment holding company primarily engaged in real estate development, investment, and related services across Mainland China, Hong Kong, Australia, and Canada. The company develops and sells residential, commercial, and integrated properties; leases investment properties; operates hotels; provides property management services; and offers loan financing, consultancy, construction and design services. It also manufactures chemical and fiber products, conducts cultural tourism business, and engages in health and wellness initiatives including Aoyuan Beauty Valley, urban redevelopment, project construction, capital investment, technology, and cross-border e-commerce. Founded in 1996 and headquartered in Guangzhou, China, with operations centered on the Guangdong-Hong Kong-Macao Greater Bay Area and extending nationwide to regions such as South China, Central and Western China, East China, and the Bohai Rim, the company owns listed subsidiaries including Aoyuan Healthy (3662.HK) and Aoyuan Beauty Valley (000615.SZ), and operates as a subsidiary of Ace Rise Profits Limited. In recent developments, China Aoyuan completed a landmark offshore debt restructuring in March 2024 through parallel schemes in Hong Kong, the Cayman Islands, and the British Virgin Islands, marking one of the first such restructurings for a Hong Kong-listed Chinese developer; sold stakes in Canadian projects such as Phase One of M2M Condos in May 2024 amid operational challenges; saw founder Guo Zi Wen sell 16.38% of shares to UAE-based Multi Gold Group in September 2024, reducing his stake to 13.3% and appointing Multi Gold's Mohamed Obaid Ghulam Badakkan Alobeidli as chairman; extended its offshore debt restructuring holding period as of September 2025; and reported 2023 revenue of RMB27.5 billion, up 47% year-over-year, with net assets turning positive post-restructuring.